Literature DB >> 33968385

Pathology of Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma.

Murli Krishna1.   

Abstract

Entities:  

Year:  2021        PMID： 33968385      PMCID： PMC8087927          DOI： 10.1002/cld.1047

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  9 in total

Review 1.  Biliary stent therapy for dominant strictures in patients affected by primary sclerosing cholangitis.

Authors:  Bassam Abu-Wasel; Valerie Keough; Paul D Renfrew; Michele Molinari
Journal:  Pathobiology       Date:  2013-05-06       Impact factor: 4.342

Review 2.  Combined hepatocellular-cholangiocarcinoma (cHCC-CC): a distinct entity.

Authors:  Kate O'Connor; Joanna C Walsh; David F Schaeffer
Journal:  Ann Hepatol       Date:  2014 May-Jun       Impact factor: 2.400

3.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

Review 4.  Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways.

Authors:  Sarinya Kongpetch; Apinya Jusakul; Choon Kiat Ong; Weng Khong Lim; Steven G Rozen; Patrick Tan; Bin Tean Teh
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-02-17       Impact factor: 3.043

Review 5.  Epidemiology of cholangiocarcinoma.

Authors:  Annika Bergquist; Erik von Seth
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-02-16       Impact factor: 3.043

Review 6.  Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis.

Authors:  Udayakumar Navaneethan; Basile Njei; Preethi G K Venkatesh; John J Vargo; Mansour A Parsi
Journal:  Gastrointest Endosc       Date:  2013-12-19       Impact factor: 9.427

7.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Authors:  Jesus M Banales; Vincenzo Cardinale; Guido Carpino; Marco Marzioni; Jesper B Andersen; Pietro Invernizzi; Guro E Lind; Trine Folseraas; Stuart J Forbes; Laura Fouassier; Andreas Geier; Diego F Calvisi; Joachim C Mertens; Michael Trauner; Antonio Benedetti; Luca Maroni; Javier Vaquero; Rocio I R Macias; Chiara Raggi; Maria J Perugorria; Eugenio Gaudio; Kirsten M Boberg; Jose J G Marin; Domenico Alvaro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-20       Impact factor: 46.802

Review 8.  Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis.

Authors:  Guru Trikudanathan; Udayakumar Navaneethan; Basile Njei; John J Vargo; Mansour A Parsi
Journal:  Gastrointest Endosc       Date:  2013-10-18       Impact factor: 9.427

Review 9.  Transplantation for cholangiocarcinoma: when and for whom?

Authors:  David J Rea; Charles B Rosen; David M Nagorney; Julie K Heimbach; Gregory J Gores
Journal:  Surg Oncol Clin N Am       Date:  2009-04       Impact factor: 3.495
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.